Apotheek Devos
ActiveSummary
Apotheek Devos has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €37,470 and a net result of -€36,501. Equity is shrinking by ~5% per year across the filed fiscal years. Its solvency ranks better than 12% of 9619 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability27▼-1
Solvency29▼-3
Growth32=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,500 at 30 days only on tighter terms
Liquidity short (current ratio 0.82 against 0.89 in 2023; short-term debt: 43.8% and cash: 9.1% of total assets), and 96.4% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
3.6%
Return on assets
-3.5%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
18192021222324
2018 to 2024 · latest year -€36,501
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 9619 sector peers (2024).
NBB · sector comparisonPosition among 9619 sector peers
Solvency
better than 12%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
27 d early
2022
33 d early
2021
26 d early
2020
18 d early
2019
32 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 28 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidy mirror How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, abbreviated schema
Equity
€37,470▼ 49.3%
2023 · €73,971
Total assets
€1.0m▼ 0.5%
2023 · €1.0m
Net result
-€36,501▼ 14.1%
2023 · -€31,997
Working capital
-€81,104▼ 110%
2023 · -€38,578
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result-€7,180▲ 69.1%€20,792€52,286▲ 151%-€18,554-€17,222▲ 7.2%
Net result-€10,538▲ 59.0%€12,800€47,117▲ 268%-€31,997-€36,501▼ 14.1%
Equity€46,050▼ 18.6%€58,850▲ 27.8%€105,968▲ 80.1%€73,971▼ 30.2%€37,470▼ 49.3%
Total assets€1.1m▼ 4.6%€1.1m▼ 1.4%€1.1m▲ 5.5%€1.0m▼ 8.8%€1.0m▼ 0.5%
Debt€1.1m▼ 3.8%€1.0m▼ 2.7%€1.0m▲ 1.2%€966,507▼ 6.6%€997,634▲ 3.2%
Working capital-€34,852▼ 42.2%-€27,500▲ 21.1%-€23,825▲ 13.4%-€38,578▼ 61.9%-€81,104▼ 110%
Staff (FTE)1.2▲ 9.1%1.2=1.3▲ 8.3%1.3=1.3=
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €17,222 in 2024 against €18,554 in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.0m
Fixed assets
€662,562 ▼ 8.6%
Current assets
€372,542 ▲ 17.9%
Equity and liabilities €1.0m
Equity
€37,470 ▼ 49.3%
Debt
€997,634 ▲ 3.2%
Debt's share of the balance-sheet total rises from 92.9% to 96.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€46,750▲
2023 · €45,924
Cash flow
€27,471▼
2023 · €32,481
Current ratio
0.82▼
2023 · 0.89
Quick ratio
0.40▲
2023 · 0.37
Debt to equity
26.63▲
2023 · 13.07
ROE
-97.4%▼
2023 · -43.3%
ROA
-3.5%▼
2023 · -3.1%
Interest coverage
1.51▼
2023 · 1.63
Debt ≤ 1 year
€453,646▲
2023 · €354,508
Debt > 1 year
€533,206▼
2023 · €601,780
Staff costs
€82,100▲
2023 · €72,511
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,038 companies that looked in July 2024 the way this one looks now, 2.9% went bankrupt within 24 months and 94% are still going.
- Micro
- 10 to 20 years old
- solvency under 10%
- a small loss
2.9%
went bankrupt
2.7%
stopped otherwise
94%
still going
A further 0.9% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.9% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,038 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €61,321 | €62,937 | €72,511 | €82,100 | ▲ 13.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €72,840 | €60,541 | €58,899 | €64,478 | €63,972 | ▼ 0.8% |
| Other operating charges640/8 | - | €24,779 | €25,559 | €24,878 | €25,809 | ▲ 3.7% |
| Gross operating margin9900 | €148,986 | €167,432 | €199,681 | €143,313 | €154,658 | ▲ 7.9% |
| Operating profit (loss)9901 | -€7,180 | €20,792 | €52,286 | -€18,554 | -€17,222 | ▲ 7.2% |
| Financial income75/76B | - | €16,593 | €18,821 | €14,728 | €11,758 | ▼ 20.2% |
| Recurring financial income75 | €19,761 | €16,593 | €18,821 | €14,728 | €11,758 | ▼ 20.2% |
| Financial charges65/66B | - | €24,585 | €23,990 | €28,171 | €31,037 | ▲ 10.2% |
| Recurring financial charges65 | €23,119 | €24,585 | €23,990 | €28,171 | €31,037 | ▲ 10.2% |
| Profit (loss) for the period before taxes9903 | -€10,538 | €12,800 | €47,117 | -€31,997 | -€36,501 | ▼ 14.1% |
| Profit (loss) for the period9904 | -€10,538 | €12,800 | €47,117 | -€31,997 | -€36,501 | ▼ 14.1% |
| Profit (loss) for the period to be appropriated9905 | -€10,538 | €12,800 | €47,117 | -€31,997 | -€36,501 | ▼ 14.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.1m | €1.1m | €1.1m | €1.0m | €1.0m | ▼ 0.5% |
| Fixed assets21/28 | €832,094 | €782,249 | €788,514 | €724,548 | €662,562 | ▼ 8.6% |
| Intangible fixed assets21 | - | €5,607 | €4,366 | €3,125 | €1,884 | ▼ 39.7% |
| Tangible fixed assets22/27 | €832,094 | €776,641 | €784,147 | €721,422 | €660,678 | ▼ 8.4% |
| Land and buildings22 | - | €734,763 | €749,966 | €695,757 | €645,509 | ▼ 7.2% |
| Plant, machinery and equipment23 | - | €38,316 | €32,483 | €23,056 | €13,630 | ▼ 40.9% |
| Furniture and vehicles24 | - | €3,561 | €1,699 | €2,609 | €1,539 | ▼ 41.0% |
| Current assets29/58 | €264,762 | €299,023 | €352,024 | €315,930 | €372,542 | ▲ 17.9% |
| Stocks and contracts in progress3 | €142,230 | €133,841 | €159,108 | €183,056 | €191,849 | ▲ 4.8% |
| Stocks30/36 | - | €133,841 | €159,108 | €183,056 | €191,849 | ▲ 4.8% |
| Amounts receivable within one year40/41 | €52,683 | €71,888 | €56,308 | €55,948 | €74,824 | ▲ 33.7% |
| Trade receivables40 | - | €69,362 | €42,344 | €52,998 | €72,107 | ▲ 36.1% |
| Other amounts receivable41 | - | €2,526 | €13,964 | €2,950 | €2,717 | ▼ 7.9% |
| Cash at bank and in hand54/58 | €60,986 | €76,574 | €119,393 | €64,245 | €93,899 | ▲ 46.2% |
| Deferred charges and accrued income490/1 | - | €16,720 | €17,215 | €12,680 | €11,969 | ▼ 5.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.1m | €1.1m | €1.1m | €1.0m | €1.0m | ▼ 0.5% |
| Equity10/15 | €46,050 | €58,850 | €105,968 | €73,971 | €37,470 | ▼ 49.3% |
| Contributions10/11 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Outside capital11 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Other1109/19 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €33,650 | €46,450 | €93,568 | €61,571 | €25,070 | ▼ 59.3% |
| Non-distributable reserves130/1 | - | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | - | - | - | - |
| Tax-exempt reserves132 | - | €1,573 | €1,573 | €1,573 | €1,573 | = |
| Distributable reserves133 | - | €43,017 | €91,994 | €59,997 | €23,497 | ▼ 60.8% |
| Amounts payable17/49 | €1.1m | €1.0m | €1.0m | €966,507 | €997,634 | ▲ 3.2% |
| Amounts payable after more than one year17 | €745,268 | €689,237 | €648,302 | €601,780 | €533,206 | ▼ 11.4% |
| Financial debts170/4 | - | €689,237 | €648,302 | €601,780 | €533,206 | ▼ 11.4% |
| Amounts payable within one year42/48 | €299,614 | €326,524 | €375,848 | €354,508 | €453,646 | ▲ 28.0% |
| Current portion of amounts payable after more than one year42 | - | €56,031 | €57,334 | €67,003 | €68,575 | ▲ 2.3% |
| Financial debts43 | - | €125,000 | €125,000 | €125,000 | €125,000 | = |
| Credit institutions430/8 | - | €125,000 | €125,000 | €125,000 | €125,000 | = |
| Trade debts44 | €34,032 | €49,367 | €103,456 | €37,946 | €86,119 | ▲ 127% |
| Suppliers440/4 | - | €49,367 | €103,456 | €37,946 | €86,119 | ▲ 127% |
| Taxes, remuneration and social security45 | - | €13,403 | €15,869 | €15,079 | €15,814 | ▲ 4.9% |
| Taxes450/3 | - | €736 | €972 | €927 | €873 | ▼ 5.8% |
| Remuneration and social security454/9 | - | €12,667 | €14,897 | €14,152 | €14,940 | ▲ 5.6% |
| Other amounts payable47/48 | - | €82,723 | €74,189 | €109,479 | €158,139 | ▲ 44.4% |
| Accrued charges and deferred income492/3 | - | €6,662 | €10,419 | €10,219 | €10,783 | ▲ 5.5% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€10,538 | €12,800 | €47,117 | -€31,997 | -€36,501 | ▼ 14.1% |
| + Depreciation and write-downs630 | €72,840 | €60,541 | €58,899 | €64,478 | €63,972 | ▼ 0.8% |
| Operating cash flow (approximation) | €62,302 | €73,341 | €106,017 | €32,481 | €27,471 | ▼ 15.4% |
| Investment in fixed assets (approximation) | - | -€10,695 | -€65,164 | -€512 | -€1,987 | ▼ 288% |
| Change in cash | - | €15,588 | €42,819 | -€55,148 | €29,654 | ▲ 154% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet -€36,501
Net result drops to -€36,501, the lowest in the series.
04-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
28-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Highest result since 2018net €47,117 ▲268%
Operating result €52,286, net result €47,117, both a record.
31-12
Financial
Equity above €100,000Eq €105,968 ▲80.1%
2 profitable years in a row build equity to €105,968.
05-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Back to profitnet €12,800
Net result €12,800 after 3 loss-making years.
13-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
29-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
10-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 31 days late
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
28-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Halle · 1 establishment unit since 2007
Ground area
354 m²
Building footprint
211 m²
Volume, LiDAR
1,815 m³
Parcel 23013A0019/02X000, Flanders · tallest building 10.7 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
APOTEEK DEVOS
since 20072.162.421.394
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23013A0019/02X000 | Flanders | 354 m² | 1 · 211 m² | 10.7 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 ownerChain of control
- Pharma Invest Devos
- Apotheek Devos
Highest known parent: Pharma Invest Devos. The sources do not say who stands above it.
Owners 1
-
99%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 3 entries · 446 EUR awarded · 446 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 108 EUR | 108 EUR |
| 2024 | 1 | 108 EUR | 108 EUR |
| 2023 | 1 | 230 EUR | 230 EUR |
Recognitions · licences · registrations
Food safety, FASFC
1 siteHalle2.162.421.394
Similar companies · same sector, comparable size
LP SOCIETY
BE 1006.284.334
Fontaine-l'Evêque · Eq €37,509
PHARMACIE BUYL
BE 0740.599.255
Elsene · Eq €37,512
Apotheek Sophie Vandewynckele
BE 1019.478.116
Eeklo · Eq €37,627
Pharm'Training Lab
BE 1002.941.891
Leuze-en-Hainaut · Eq €37,760
APOTHEEK JULIE BORGHIJS
BE 0860.855.994
Aartselaar · Eq €37,795
Of 5,220 companies in sector 47730 we hold annual accounts for 3,860. 2,345 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded12-04-2007
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0888712416
Also
9925:BE0888712416
Registered
07-12-2025
Register as of 26 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.